Runnymede Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-225	Closed	-$15.6K	–	197
2025 Q1	$15.6K	Hold	225	–	–	0.02%	190
2024 Q4	$19.4K	Buy	+225	New	+$19.4K	0.02%	181